Arcellx Inc (ACLX)
87.15
-0.07
(-0.08%)
USD |
NASDAQ |
Nov 21, 16:00
87.15
0.00 (0.00%)
After-Hours: 20:00
Arcellx 1 Year Total Returns (Daily): 65.75% for Nov. 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 20, 2024 | 65.75% |
November 19, 2024 | 58.65% |
November 18, 2024 | 59.79% |
November 15, 2024 | 75.70% |
November 14, 2024 | 100.3% |
November 13, 2024 | 120.1% |
November 12, 2024 | 120.8% |
November 11, 2024 | 134.1% |
November 08, 2024 | 124.7% |
November 07, 2024 | 107.7% |
November 06, 2024 | 105.3% |
November 05, 2024 | 95.20% |
November 04, 2024 | 93.68% |
November 01, 2024 | 150.6% |
October 31, 2024 | 139.1% |
October 30, 2024 | 154.3% |
October 29, 2024 | 174.8% |
October 28, 2024 | 167.7% |
October 25, 2024 | 160.5% |
October 24, 2024 | 152.8% |
October 23, 2024 | 172.4% |
October 22, 2024 | 171.4% |
October 21, 2024 | 170.9% |
October 18, 2024 | 185.0% |
October 17, 2024 | 171.0% |
Date | Value |
---|---|
October 16, 2024 | 173.0% |
October 15, 2024 | 171.4% |
October 14, 2024 | 162.0% |
October 11, 2024 | 139.9% |
October 10, 2024 | 127.7% |
October 09, 2024 | 130.6% |
October 08, 2024 | 123.5% |
October 07, 2024 | 110.3% |
October 04, 2024 | 129.2% |
October 03, 2024 | 123.6% |
October 02, 2024 | 119.9% |
October 01, 2024 | 127.0% |
September 30, 2024 | 132.7% |
September 27, 2024 | 136.7% |
September 26, 2024 | 142.8% |
September 25, 2024 | 144.9% |
September 24, 2024 | 148.6% |
September 23, 2024 | 153.2% |
September 20, 2024 | 151.0% |
September 19, 2024 | 136.1% |
September 18, 2024 | 137.7% |
September 17, 2024 | 135.9% |
September 16, 2024 | 132.9% |
September 13, 2024 | 129.9% |
September 12, 2024 | 116.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
6.07%
Minimum
May 10 2024
471.4%
Maximum
May 18 2023
109.2%
Average
89.73%
Median
1 Year Total Returns (Daily) Benchmarks
Boston Scientific Corp | 65.57% |
AbbVie Inc | 25.77% |
NovaBay Pharmaceuticals Inc | -93.75% |
Palatin Technologies Inc | -53.12% |
iBio Inc | -57.88% |